Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mycophenolate in dermatology.

V Liu1, B T Mackool

  • 1Department of Dermatology, Harvard Medical School, Massachusetts General Hospital Dermatopathology Unit, 55 Fruit Street, Boston, MA 02114, USA. bmackool@partners.org

The Journal of Dermatological Treatment
|December 9, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Marginal warming associated with a COVID-19 quarantine and the implications for disease transmission.

The Science of the total environment·2021
Same author

Spreading violaceous neck plaques in a fatigued man.

Clinical and experimental dermatology·2021
Same author

The prevalence and significance of radiographic incidental findings during initial staging of melanoma: a retrospective study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Systemic lupus erythematosus-associated neutrophilic dermatosis manifesting as an acneiform eruption and foot pain.

Clinical and experimental dermatology·2019
Same author

FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Localized, ovoid urticarial plaques with fine, nonfollicular pustules.

Clinical and experimental dermatology·2017
Same journal

Active surveillance for basal cell carcinoma: experiences of patients and proxies.

The Journal of dermatological treatment·2026
Same journal

Severe cutaneous adverse reactions associated with systemic antibiotics in acne vulgaris: a systematic review.

The Journal of dermatological treatment·2026
Same journal

Intralesional human papillomavirus vaccination for cutaneous verrucae: a systematic review and meta-analysis of therapeutic efficacy.

The Journal of dermatological treatment·2026
Same journal

JAK inhibitor-associated acne: a mechanistic paradox with important clinical implications.

The Journal of dermatological treatment·2026
Same journal

Efficacy of vunakizumab in patients with moderate-to-severe plaque psoriasis across diverse disease features: a <i>post hoc</i> analysis of a phase-III trial.

The Journal of dermatological treatment·2026
Same journal

Predictors of optimal disease control in atopic dermatitis with abrocitinib: a real-world study.

The Journal of dermatological treatment·2026
See all related articles

Mycophenolate mofetil (MMF), an immunosuppressant, shows promise for various skin diseases beyond psoriasis. Dermatologists are exploring its efficacy for conditions like pemphigus vulgaris and lupus erythematosus.

Area of Science:

  • Immunodermatology
  • Pharmacology
  • Dermatology

Background:

  • Mycophenolic acid, reformulated as mycophenolate mofetil (MMF), was initially used for psoriasis.
  • MMF is a well-tolerated immunosuppressant commonly used in organ transplantation.
  • Recent literature suggests MMF's potential in treating various dermatologic conditions.

Purpose of the Study:

  • To review the pharmacology, side effects, and efficacy of MMF in dermatologic indications.
  • To consolidate existing case reports and series on MMF's use in skin diseases.
  • To assess the potential of MMF as a treatment option in dermatology.

Main Methods:

  • Literature search of Medline database.
  • Keywords used: "mycophenolate" or "mycophenolic acid" combined with "skin" or specific dermatologic conditions.

Related Experiment Videos

  • Review of case reports and case series detailing MMF's dermatologic application.

    • Main Results:

    • MMF demonstrates promise in treating conditions such as psoriasis, pemphigus vulgaris, pyoderma gangrenosum, bullous lichen planus, lupus erythematosus, and dermatomyositis.
    • The drug is generally well-tolerated, with a known profile from its use in transplant recipients.
    • Existing studies, primarily case reports, indicate positive outcomes for several dermatologic conditions.

    Conclusions:

    • MMF is a promising therapeutic agent for a range of dermatologic diseases.
    • Further large-scale, controlled studies are warranted to confirm MMF's efficacy and safety in dermatology.
    • The re-emergence of MMF in dermatology offers a potential new treatment avenue for complex skin conditions.